INTERNATIONAL PATENT: LA JOLLA INSTITUTE FOR IMMUNOLOGY FILES APPLICATION FOR "PREFUSION-STABILIZED SARS-COV-2 SPIKE S2 SUBUNIT AS ANTIGEN FOR BROAD PAN-CORONAVIRUS VACCINES"

GENEVA, May 28 -- LA JOLLA INSTITUTE FOR IMMUNOLOGY (9420 Athena CircleLa Jolla, CA 92037) filed a patent application (PCT/US2024/056091) for "PREFUSION-STABILIZED SARS-COV-2 SPIKE S2 SUBUNIT AS ANTIGEN FOR BROAD PAN-CORONAVIRUS VACCINES" on Nov 15, 2024. With publication no. WO/2025/106792, the details related to the patent application was published on May 22, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SAPHIRE, Erica, Ollmann (c/o La Jolla Institute for Immunology9420 Athena CircleLa Jolla, CA 92037), OLMEDILLAS, Eduardo (c/o La Jolla Institute for Immunology9420 Athena CircleLa Jolla,...